Dr. Zhou Jun (周俊) — GI Oncology & Cell Therapy | Gaobo Hospital Shanghai
For international patients with gastric cancer, colorectal cancer, or hepatobiliary tumors who have exhausted standard treatment options — or who are seeking access to cutting-edge cell therapies not yet available in their home country — Dr. Zhou Jun (周俊) represents one of the most forward-looking oncologists in China today. As Deputy Dean and Director of GI Oncology at Gaobo Hospital Shanghai, Dr. Zhou combines comprehensive expertise in digestive system tumors with a pioneering role in clinical cell therapy research.
Specialty Focus
- Gastric cancer: comprehensive treatment including targeted therapy, immunotherapy, and cell therapy
- Colorectal cancer: systemic treatment, immunotherapy, and novel cellular approaches
- Hepatobiliary and pancreatic tumors: integrated oncological management
- CAR-T cell therapy clinical research for solid tumors
- TIL (tumor-infiltrating lymphocyte) therapy
- Combination strategies: cell therapy + targeted therapy + immunotherapy
Academic & Clinical Titles
- Chief Physician (主任医师) & Professor
- Deputy Dean (医疗副院长), Gaobo Hospital Shanghai
- Director, Department of GI Oncology (消化肿瘤科主任), Gaobo Hospital Shanghai
- Recipient of the "People's Famous Physician" (人民名医) honor
A National Pioneer in Cell Therapy for Solid Tumors
Dr. Zhou Jun's most distinctive contribution to oncology in China is his early and sustained commitment to cellular immunotherapy for solid tumors — a field that remains at the frontier of cancer treatment globally. While CAR-T therapy has achieved remarkable results in blood cancers, its application to solid tumors such as gastric and colorectal cancer is far more complex, and only a handful of centers in China have the clinical infrastructure and expertise to pursue it rigorously.
Dr. Zhou is recognized as one of the earliest pioneers in China to initiate CAR-T and TIL clinical research for digestive system cancers. This means that patients under his care may have access to investigational cell therapy protocols that are simply not available at most oncology centers — in China or internationally.
CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) involves engineering a patient's own immune cells to recognize and attack cancer cells. TIL therapy (Tumor-Infiltrating Lymphocyte therapy) harvests immune cells that have already infiltrated the tumor, expands them in the laboratory, and reinfuses them to mount a more powerful anti-tumor response. Both approaches represent the next generation of cancer immunotherapy, and Dr. Zhou's team has been building clinical experience with these modalities for years.
Comprehensive GI Oncology: Beyond Cell Therapy
Gastric Cancer: China has one of the world's highest incidences of gastric cancer, and Dr. Zhou's team has extensive experience managing all stages — from resectable early-stage disease to advanced metastatic gastric cancer. Treatment planning integrates HER2 status, PD-L1 expression, and microsatellite instability (MSI) profiling to guide targeted and immunotherapy selection.
Colorectal Cancer: For patients with metastatic colorectal cancer, Dr. Zhou's team evaluates RAS/RAF mutation status, MSI-H/dMMR eligibility for immunotherapy, and the role of liver-directed therapies in oligometastatic disease. Novel cellular approaches are considered for patients who have progressed on standard regimens.
Hepatobiliary & Pancreatic Tumors: These tumors remain among the most challenging in oncology. Dr. Zhou's integrated approach combines systemic therapy with multidisciplinary coordination involving hepatobiliary surgery, interventional radiology, and radiation oncology.
Gaobo Hospital Shanghai: A Specialized Oncology Institution
Gaobo Hospital Shanghai is a specialized oncology hospital with a particular focus on innovative therapies, including cell therapy clinical programs. Unlike large general hospitals where oncology is one department among many, Gaobo's institutional focus on cancer treatment creates an environment where novel protocols can be developed and implemented with greater agility. For patients seeking access to clinical trials or investigational therapies, this institutional context is significant.
Who Should Consider Consulting Dr. Zhou Jun
- Patients with advanced gastric, colorectal, or hepatobiliary cancer who have progressed on first- or second-line standard therapy
- Patients interested in CAR-T or TIL cell therapy clinical trials for solid tumors
- Patients seeking a second opinion on immunotherapy eligibility (PD-L1, MSI-H, TMB status)
- Patients with rare GI tumor subtypes where local oncologists have limited experience
- Patients from countries where access to combination immunotherapy + targeted therapy regimens is limited
How CMCS Connects You with Dr. Zhou Jun
China Medical Concierge Shanghai (CMCS) facilitates access to Dr. Zhou Jun for international patients seeking expert evaluation or treatment for digestive system cancers. Our team manages the full coordination process — from remote case review and medical record translation to appointment scheduling, interpretation, and in-hospital support throughout the consultation and treatment process.
To begin, patients or their families are encouraged to share available medical records, pathology reports (including molecular profiling results), imaging studies (CT, PET-CT, MRI), and prior treatment summaries. Dr. Zhou's team can conduct an initial remote assessment to determine whether in-person consultation or cell therapy eligibility evaluation is appropriate before any travel to Shanghai is required.
CMCS provides end-to-end support, including:
- Medical record translation (English, Arabic, French, and other languages)
- Remote pre-consultation case review and eligibility assessment
- Appointment coordination with Dr. Zhou Jun's clinic at Gaobo Hospital
- On-site interpretation during consultations and procedures
- Coordination with cell therapy, surgical, and radiology teams as needed
- Post-consultation summary and ongoing follow-up support
Contact CMCS to Connect with Dr. Zhou Jun
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS – China Medical Concierge Shanghai connects international patients with Shanghai's leading specialists. We are a health management company, not a hospital. All clinical decisions are made by the treating physician.
0 comentarios